戻る
SinoMab BioScience Limited (03681.HK)価格
03681.HK 株価推移チャート
SINOMAB BIO-B (03681.HK)
SinoMab BioScience Limited
HK$1.44
-6.49%
$-0.1
休場: Jan 16, 16:00:00 HKT
主要データ
前終値
$1.54
始値
$1.54
当日レンジ
$1.44 - $1.54
52週レンジ
$0.8 - $3.76
取引高
4.2M
平均取引高
5.9M
1株当たり利益(TTM)
-0.16
配当利回り
--
時価総額
$1.9B
SINOMAB BIO-Bとは何ですか？
SinoMab Bioscience Ltd. is a clinical stage biopharmaceutical company, which engages in the research, development, and manufacture of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody-based biologics. The company employs 61 full-time employees The company went IPO on 2019-11-12. The firm primarily develops mAb-based biologics and new chemical entities (NCE) and its product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The firm is also developing drugs such as SM17, which has the potential to treat atopic dermatitis (AD), asthma, idiopathic pulmonary fibrosis (IPF) and other immune diseases, and SN1011, which targets systemic lupus erythematosus (SLE), pemphigus, multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD).
